Controversial Ginkgo Will Team With Persephone On Bacterial Delivery Of Microbial Therapies

Deal Snapshot: In its third biopharma collaboration this year, Ginkgo will apply its genetic engineering technologies to using Bacteroides for stable delivery of microbiome medicines.

Synthetic biology
Ginkgo BioWorks signs its third synthetic biology partnership of 2022 • Source: Alamy

More from Deals

More from Business